24
Views
14
CrossRef citations to date
0
Altmetric
Original Article

The interaction between human FCγRI and the γ-chain is mediated solely via the 21 amino acid transmembrane domain of FCγRI

, , &
Pages 309-312 | Received 16 Jun 1995, Published online: 09 Jul 2009
 

Abstract

We have established a biological assay to investigate the nature of the non-covalent interaction between two integral type I membrane proteins, FCγRI and γ-chain. FCγRI, the human high affinity receptor for immunoglobulin G (IgG), is expressed on the surface of macrophages and monocytes and mediates a broad range of important immunological functions. FCγRI relies on a functional interaction with a second integral type I membrane protein, γ-chain, to mediate many of these functions. For example, FCγRI can only mediate phagocytosis of IgG-coated particles in COS cells when co-expressed with γ-chain. We have previously shown that the cytoplasmic domain of FCγRI is not necessary for this functional interaction. In this study we have used the phagocytosis assay to investigate the role of the transmembrane region of FCγRI in mediating this functional interaction with γ-chain by using mutant and chimeric forms of the receptor. Three mutants, which introduce or remove charged residues from a conserved 10 amino acid stretch of amino acids in the proximal transmembrane region of FCγRI, were able to mediate phagocytosis of IgG-coated particles. In contrast, two chimeric receptors, in which 21 of the amino acids in the distal transmembrane region of FCγRI were replaced with the transmembrane region of the related receptors CD2 or LFA3, were expressed but failed to interact functionally with γ-chain to mediate phagocytosis. Thus, these mutants demonstrate that the interaction between human FCγRI and γ-chain is mediated solely via these 21 amino acids in the transmembrane domain of FCγRI.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.